| Richard L Weyman Iv, MD | |
|
2222 53rd Ave, Bettendorf, IA 52722-7546 | |
| (563) 383-2686 | |
| (563) 884-8144 |
| Full Name | Richard L Weyman Iv |
|---|---|
| Gender | Male |
| Speciality | Gastroenterology |
| Experience | 31 Years |
| Location | 2222 53rd Ave, Bettendorf, Iowa |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295717478 | NPI | - | NPPES |
| 0184267 | Medicaid | IA | |
| 1238640 | Other | IA | CSA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | 31175 (Iowa) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Genesis Medical Center-davenport | Davenport, IA | Hospital |
| Genesis Medical Center-dewitt | Dewitt, IA | Hospital |
| Genesis Hlth System Dba Genesis Mdl Ctr-illini | Silvis, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Genesis Health System | 6103829338 | 186 |
News Archive
Trius Therapeutics, Inc. announced that on February 26th, 2010, the FDA issued new draft guidance on non-inferiority clinical trials that will apply to the design of the Company's proposed Phase 3 trials for its investigational antibacterial drug torezolid phosphate.
Researchers have found that environment has a much stronger role than genetics in eosinophilic esophagitis (EoE), a severe, often painful food allergy that renders children unable to eat a wide variety of foods.
Today, the International Rett Syndrome Foundation (IRSF) announced that it will commit $446,000 in 2010 to fund a large translational research program to test potential therapeutics for Rett Syndrome in mouse models of the disease. The funds will be awarded through the IRSF's new Advanced Neurotherapeutic Grant of Excellence (ANGEL) mechanism which seeks to provide funds for translational research. IRSF is the world's largest private source of Rett syndrome research funding, supporting nearly $21 million in research programs to date. This is the first ANGEL Grant supported by IRSF in 2010.
Natural infection with COVID-19 offered protection from reinfection when the gamma and delta variants predominated, according to a new University of Michigan study that also provides levels of antibodies needed to protect against reinfections.
› Verified 7 days ago
| Entity Name | Gastroenterology Associates, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821022161 PECOS PAC ID: 6305738808 Enrollment ID: O20040329000871 |
News Archive
Trius Therapeutics, Inc. announced that on February 26th, 2010, the FDA issued new draft guidance on non-inferiority clinical trials that will apply to the design of the Company's proposed Phase 3 trials for its investigational antibacterial drug torezolid phosphate.
Researchers have found that environment has a much stronger role than genetics in eosinophilic esophagitis (EoE), a severe, often painful food allergy that renders children unable to eat a wide variety of foods.
Today, the International Rett Syndrome Foundation (IRSF) announced that it will commit $446,000 in 2010 to fund a large translational research program to test potential therapeutics for Rett Syndrome in mouse models of the disease. The funds will be awarded through the IRSF's new Advanced Neurotherapeutic Grant of Excellence (ANGEL) mechanism which seeks to provide funds for translational research. IRSF is the world's largest private source of Rett syndrome research funding, supporting nearly $21 million in research programs to date. This is the first ANGEL Grant supported by IRSF in 2010.
Natural infection with COVID-19 offered protection from reinfection when the gamma and delta variants predominated, according to a new University of Michigan study that also provides levels of antibodies needed to protect against reinfections.
› Verified 7 days ago
| Entity Name | Genesis Health System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528616901 PECOS PAC ID: 6103829338 Enrollment ID: O20191031002622 |
News Archive
Trius Therapeutics, Inc. announced that on February 26th, 2010, the FDA issued new draft guidance on non-inferiority clinical trials that will apply to the design of the Company's proposed Phase 3 trials for its investigational antibacterial drug torezolid phosphate.
Researchers have found that environment has a much stronger role than genetics in eosinophilic esophagitis (EoE), a severe, often painful food allergy that renders children unable to eat a wide variety of foods.
Today, the International Rett Syndrome Foundation (IRSF) announced that it will commit $446,000 in 2010 to fund a large translational research program to test potential therapeutics for Rett Syndrome in mouse models of the disease. The funds will be awarded through the IRSF's new Advanced Neurotherapeutic Grant of Excellence (ANGEL) mechanism which seeks to provide funds for translational research. IRSF is the world's largest private source of Rett syndrome research funding, supporting nearly $21 million in research programs to date. This is the first ANGEL Grant supported by IRSF in 2010.
Natural infection with COVID-19 offered protection from reinfection when the gamma and delta variants predominated, according to a new University of Michigan study that also provides levels of antibodies needed to protect against reinfections.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Richard L Weyman Iv, MD 2222 53rd Ave, Bettendorf, IA 52722-7546 Ph: (563) 383-2686 | Richard L Weyman Iv, MD 2222 53rd Ave, Bettendorf, IA 52722-7546 Ph: (563) 383-2686 |
News Archive
Trius Therapeutics, Inc. announced that on February 26th, 2010, the FDA issued new draft guidance on non-inferiority clinical trials that will apply to the design of the Company's proposed Phase 3 trials for its investigational antibacterial drug torezolid phosphate.
Researchers have found that environment has a much stronger role than genetics in eosinophilic esophagitis (EoE), a severe, often painful food allergy that renders children unable to eat a wide variety of foods.
Today, the International Rett Syndrome Foundation (IRSF) announced that it will commit $446,000 in 2010 to fund a large translational research program to test potential therapeutics for Rett Syndrome in mouse models of the disease. The funds will be awarded through the IRSF's new Advanced Neurotherapeutic Grant of Excellence (ANGEL) mechanism which seeks to provide funds for translational research. IRSF is the world's largest private source of Rett syndrome research funding, supporting nearly $21 million in research programs to date. This is the first ANGEL Grant supported by IRSF in 2010.
Natural infection with COVID-19 offered protection from reinfection when the gamma and delta variants predominated, according to a new University of Michigan study that also provides levels of antibodies needed to protect against reinfections.
› Verified 7 days ago
Dr. Ronald Brent Schlotfeldt Ii, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 4480 Utica Ridge Rd, Ste 2230, Bettendorf, IA 52722 Phone: 563-742-5150 Fax: 563-742-5165 | |
Douglas Earl Vickstrom, MD Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 2979 Victoria St, Va Opt Clinic, Bettendorf, IA 52722 Phone: 563-332-8528 Fax: 563-332-9331 | |
David S Pratt, MD Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 2222 53rd Ave, Bettendorf, IA 52722 Phone: 563-383-2686 Fax: 563-884-8144 | |
Carrie Stripling, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 3705 Utica Ridge Rd, Bettendorf, IA 52722 Phone: 563-324-8160 | |
William P Jerome, MD Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 4480 Utica Ridge Rd, Suite 2230, Bettendorf, IA 52722 Phone: 563-742-5150 Fax: 563-742-5165 | |
William Davidson Iii, M.D. Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 2222 53rd Ave, Bettendorf, IA 52722 Phone: 563-383-2686 Fax: 563-884-8144 | |
Dr. Lindsay Jo Orris, D.O. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 2979 Victoria St, Bettendorf, IA 52722 Phone: 563-359-4440 Fax: 563-359-4644 |